Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis.
Khan
Sujoy
S
D000368:Aged; D018501:Antirheumatic Agents / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D006331:Heart Diseases / Q000139:chemically induced / Q000209:etiology*; D006801:Humans; D008954:Models, Biological; D011480:Protease Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D046988:Proteasome Endopeptidase Complex; D061988:Proteasome Inhibitors; D013583:Synovial Membrane / Q000187:drug effects / Q000201:enzymology / Q000473:pathology
D018501:Antirheumatic Agents; D011480:Protease Inhibitors; D061988:Proteasome Inhibitors; D046988:Proteasome Endopeptidase Complex; C061553:ATP dependent 26S protease